390 related articles for article (PubMed ID: 22396515)
1. Effect of testosterone supplementation with and without a dual 5α-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial.
Bhasin S; Travison TG; Storer TW; Lakshman K; Kaushik M; Mazer NA; Ngyuen AH; Davda MN; Jara H; Aakil A; Anderson S; Knapp PE; Hanka S; Mohammed N; Daou P; Miciek R; Ulloor J; Zhang A; Brooks B; Orwoll K; Hede-Brierley L; Eder R; Elmi A; Bhasin G; Collins L; Singh R; Basaria S
JAMA; 2012 Mar; 307(9):931-9. PubMed ID: 22396515
[TBL] [Abstract][Full Text] [Related]
2. The role of 5α-reductase inhibition in men receiving testosterone replacement therapy.
Gruntmanis U
JAMA; 2012 Mar; 307(9):968-70. PubMed ID: 22396520
[No Abstract] [Full Text] [Related]
3. Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy.
Page ST; Hirano L; Gilchriest J; Dighe M; Amory JK; Marck BT; Matsumoto AM
J Urol; 2011 Jul; 186(1):191-7. PubMed ID: 21575967
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5α-reductase inhibitors.
Wu Y; Godoy A; Azzouni F; Wilton JH; Ip C; Mohler JL
Prostate; 2013 Sep; 73(13):1470-82. PubMed ID: 23813697
[TBL] [Abstract][Full Text] [Related]
5. Testosterone with dutasteride, but not anastrazole, improves insulin sensitivity in young obese men: a randomized controlled trial.
Juang PS; Peng S; Allehmazedeh K; Shah A; Coviello AD; Herbst KL
J Sex Med; 2014 Feb; 11(2):563-73. PubMed ID: 24344872
[TBL] [Abstract][Full Text] [Related]
6. 5α-reductase type 1 modulates insulin sensitivity in men.
Upreti R; Hughes KA; Livingstone DE; Gray CD; Minns FC; Macfarlane DP; Marshall I; Stewart LH; Walker BR; Andrew R
J Clin Endocrinol Metab; 2014 Aug; 99(8):E1397-406. PubMed ID: 24823464
[TBL] [Abstract][Full Text] [Related]
7. Dutasteride in men receiving testosterone therapy: a randomised, double-blind study.
Kacker R; Harisaran V; Given L; Miner M; Rittmaster R; Morgentaler A
Andrologia; 2015 Mar; 47(2):148-52. PubMed ID: 24499051
[TBL] [Abstract][Full Text] [Related]
8. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
World J Urol; 2002 Apr; 19(6):413-25. PubMed ID: 12022710
[TBL] [Abstract][Full Text] [Related]
9. A Randomized Double-Blind Placebo-Controlled Pilot Trial on the Effects of Testosterone Undecanoate Plus Dutasteride or Placebo on Muscle Strength, Body Composition, and Metabolic Profile in Transmen.
Gava G; Armillotta F; Pillastrini P; Giagio S; Alvisi S; Mancini I; Morselli PG; Seracchioli R; Meriggiola MC
J Sex Med; 2021 Mar; 18(3):646-655. PubMed ID: 33531255
[TBL] [Abstract][Full Text] [Related]
10. Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial.
Borst SE; Yarrow JF; Conover CF; Nseyo U; Meuleman JR; Lipinska JA; Braith RW; Beck DT; Martin JS; Morrow M; Roessner S; Beggs LA; McCoy SC; Cannady DF; Shuster JJ
Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E433-42. PubMed ID: 24326421
[TBL] [Abstract][Full Text] [Related]
11. The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia.
Wurzel R; Ray P; Major-Walker K; Shannon J; Rittmaster R
Prostate Cancer Prostatic Dis; 2007; 10(2):149-54. PubMed ID: 17189955
[TBL] [Abstract][Full Text] [Related]
12. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
Schwartz JI; Tanaka WK; Wang DZ; Ebel DL; Geissler LA; Dallob A; Hafkin B; Gertz BJ
J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518
[TBL] [Abstract][Full Text] [Related]
13. The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men.
Amory JK; Wang C; Swerdloff RS; Anawalt BD; Matsumoto AM; Bremner WJ; Walker SE; Haberer LJ; Clark RV
J Clin Endocrinol Metab; 2007 May; 92(5):1659-65. PubMed ID: 17299062
[TBL] [Abstract][Full Text] [Related]
14. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.
Clark RV; Hermann DJ; Cunningham GR; Wilson TH; Morrill BB; Hobbs S
J Clin Endocrinol Metab; 2004 May; 89(5):2179-84. PubMed ID: 15126539
[TBL] [Abstract][Full Text] [Related]
15. The rationale for inhibiting 5alpha-reductase isoenzymes in the prevention and treatment of prostate cancer.
Tindall DJ; Rittmaster RS
J Urol; 2008 Apr; 179(4):1235-42. PubMed ID: 18280514
[TBL] [Abstract][Full Text] [Related]
16. Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial.
Muller RL; Gerber L; Moreira DM; Andriole G; Castro-Santamaria R; Freedland SJ
Eur Urol; 2012 Nov; 62(5):757-64. PubMed ID: 22658758
[TBL] [Abstract][Full Text] [Related]
17. Dutasteride: a potent dual inhibitor of 5-alpha-reductase for benign prostatic hyperplasia.
Rabasseda X
Drugs Today (Barc); 2004 Aug; 40(8):649-61. PubMed ID: 15510237
[TBL] [Abstract][Full Text] [Related]
18. Relationship among serum testosterone, sexual function, and response to treatment in men receiving dutasteride for benign prostatic hyperplasia.
Marberger M; Roehrborn CG; Marks LS; Wilson T; Rittmaster RS
J Clin Endocrinol Metab; 2006 Apr; 91(4):1323-8. PubMed ID: 16434455
[TBL] [Abstract][Full Text] [Related]
19. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle.
Bhasin S; Woodhouse L; Casaburi R; Singh AB; Mac RP; Lee M; Yarasheski KE; Sinha-Hikim I; Dzekov C; Dzekov J; Magliano L; Storer TW
J Clin Endocrinol Metab; 2005 Feb; 90(2):678-88. PubMed ID: 15562020
[TBL] [Abstract][Full Text] [Related]
20. The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men.
Amory JK; Anawalt BD; Matsumoto AM; Page ST; Bremner WJ; Wang C; Swerdloff RS; Clark RV
J Urol; 2008 Jun; 179(6):2333-8. PubMed ID: 18423697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]